LOGANNE WERTZ: Open Payments
NPI 1497362438 · LONGMONT, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$702 in 30 payments from 18 companies in 2025. Trend: 2023 $1,675 · 2024 $1,628 · 2025 $702
Food & beverage: $634Education: $68
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $142 |
| Merck Sharp & Dohme LLC | 3 | $74 |
| TOLMAR, INC. | 2 | $58 |
| UROGEN PHARMA, INC. | 2 | $51 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $48 |
| 180 Medical, Inc. | 2 | $46 |
| Laborie Medical Technologies Corp. | 2 | $41 |
| Astellas Pharma US Inc | 2 | $33 |
| PFIZER INC. | 2 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $30 |
Products named: ERLEADA, KEYTRUDA, XTANDI, JATENZO, JELMYTO, JOURNAVX, CURE CATHETER, ORGOVYX.
Industry payments across CO — which companies pay providers there.
